[Risedronate: clinical usage].
Shiraki
Masataka
M
Research Institute and Practice for Involutional Disease.
D015519:Bone Density; D002986:Clinical Trials as Topic; D012968:Etidronic Acid / Q000031:analogs & derivatives* / Q000493:pharmacokinetics / Q000627:therapeutic use*; D005265:Femoral Neck Fractures / Q000517:prevention & control; D015775:Fractures, Stress / Q000517:prevention & control; D006801:Humans; D010001:Osteitis Deformans / Q000188:drug therapy; D010024:Osteoporosis / Q000188:drug therapy* / Q000209:etiology / Q000517:prevention & control; D011241:Prednisone / Q000009:adverse effects; D000068296:Risedronic Acid; D016103:Spinal Fractures / Q000517:prevention & control
D000068296:Risedronic Acid; D012968:Etidronic Acid; D011241:Prednisone